• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Screening
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

Elevated Triglycerides in a Woman with Type 2 Diabetes

Poll

What do current guidelines recommend as first-line treatment for patients like 51-year-old TK? Check out these options.

TK is a 51-year-old woman who presents to the clinic for diabetes follow-up. Her past medical history includes type 2 diabetes (T2DM), hypertension, and dyslipidemia. She has no known drug allergies and is a non-smoker.

Her current medications are:  
  * Metformin 1000 mg twice daily
  * Losartan/HCTZ 100/25 mg daily
  * Aspirin 81 mg daily

Labs are drawn today and include:
  * HbA1c, 7.1%
  * Complete metabolic panel: WNL (SCr, 0.7; Na+, 139; K+, 4.5; AST,  23; ALT, 26)  
  * Lipid panel: TC, 230; TG, 365; HDL, 41; LDL, 124  
 
Vital signs:

  * Weight, 82 kg; BMI, 33; blood pressure in clinic, 124/80 and 128/76 mmHg;
    pulse,  82 beats/min 

What should be done to treat her dyslipidemia?

A. Add atorvastatin 10 mg daily
B. Add atorvastatin 10 mg daily and niacin SR 1000 mg twice daily
C. Add atorvastatin 10 mg daily and fenofibrate 160 mg daily
D. Add fenofibrate 160 mg daily
E. Encourage lifestyle modifications and continue current medications
Related Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
© 2024 MJH Life Sciences

All rights reserved.